Comprehensive analysis of pan-cancer reveals potential of ASF1B as a prognostic and immunological biomarker.
Xinyao HuHua ZhuXiaoyu ZhangXiaoqin HeXiming XuPublished in: Cancer medicine (2021)
Our findings show that ASF1B may serve as a prognostic marker and potential immunotherapeutic target for several malignancies due to its role in tumorigenesis and immune infiltration.